We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

54 hedge funds and large institutions have $64.8M invested in Strongbridge Biopharma plc. in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 58 → 54 (-4)

26% less capital invested

Capital invested by funds: $87.2M → $64.8M (-$22.3M)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
23
Reduced
13
Closed
11
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.28M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.01M
3
Northern Trust
Northern Trust
Illinois
+$818K
4
BlackRock
BlackRock
New York
+$614K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$577K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$4.95M
2
OM
Opaleye Management
Massachusetts
-$1.75M
3
SCM
Stonepine Capital Management
Oregon
-$508K
4
BFM
Boothbay Fund Management
New York
-$376K
5
Jane Street
Jane Street
New York
-$257K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$3.97K +$4.46K +1,660 New
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$2K -$986 -367 -28%
CSS
53
Cubist Systematic Strategies
Connecticut
$2K +$2.49K +928 New
Daiwa Securities Group
54
Daiwa Securities Group
Japan
$1K – – –
AC
55
Armistice Capital
New York
– -$4.95M -1,580,000 Closed
SCM
56
Stonepine Capital Management
Oregon
– -$508K -162,244 Closed
BFM
57
Boothbay Fund Management
New York
– -$376K -120,000 Closed
Jane Street
58
Jane Street
New York
– -$257K -82,040 Closed
PWAM
59
Park West Asset Management
California
– -$239K -76,446 Closed
JG
60
Jefferies Group
New York
– -$157K -50,000 Closed
HF
61
HRT Financial
New York
– -$63K -20,422 Closed
Stifel Financial
62
Stifel Financial
Missouri
– -$53K -16,800 Closed
SCM
63
Stonebridge Capital Management
California
– -$41K -12,950 Closed
CG
64
Cutler Group
California
– -$3K -1,000 Closed
Fidelity Investments
65
Fidelity Investments
Massachusetts
– -$2K -588 Closed
1 2
3

SBBP Hedge Fund Activity: Q3 2019 in Review

54 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q3 2019, worth a combined $64.8M — down 26% from $87.2M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SBBP and 7 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 23 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $1.28M. The largest seller was Armistice Capital, exiting entirely with an estimated $4.95M sold.

  • 54 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q3 2019, down from 58 in Q2 2019.
  • Funds reported $64.8M of Strongbridge Biopharma plc. stock for Q3 2019, down 26% quarter-over-quarter.
  • 7 funds opened new Strongbridge Biopharma plc. positions in Q3 2019 and 11 closed out, a net change of -4 holders.
  • The largest Strongbridge Biopharma plc. buyer in Q3 2019 was Point72 Asset Management, an estimated $1.28M added.
  • The largest Strongbridge Biopharma plc. seller in Q3 2019 was Armistice Capital, an estimated $4.95M sold.

Based on aggregated 13F filings for Q3 2019.